Vilanterol + fluticasone (RELVAR Ellipta) . Asthma and COPD: yet another beta-2 agonist and corticosteroid combination
Prescrire International 25(170): 94
2016
ISSN/ISBN: 1167-7422 PMID: 27186620 Document Number: 689635
As expected, the vilanterol + fluticasone combination increases the risk of pneumonia in patients with COPD.
Document emailed within 1 workday
Related Documents
Walsh, J.; Murphy, D.M. 2019: Combination Inhaled Corticosteroid/Long Acting Beta Agonist Therapy- An Evolving Role in Asthma Care Irish Medical Journal 112(2): 864Sienra Monge, J.J.; Bermejo Guevara, M.A.; del Río Navarro, B.E.; Rosas Vargas, M.A.; Reyes Ruiz, N.I. 2000: Degree and duration of bronchodilatation with an agonist beta 2 administered alone versus an agonist beta 2 administered with ipratropium bromide in children with acute asthma Revista Alergia Mexico 47(1): 26-29
Sheffer, A.L.; LaForce, C.; Chervinsky, P.; Pearlman, D.; Schaberg, A. 1996: Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group Journal of Family Practice 42(4): 369-375
D'Amato, G. 2008: World Asthma and COPD Forum. Tackling asthma, COPD and allergic diseases IDrugs: the investigational drugs journal 11(7): 486-488
Suissa, S.; Ernst, P.; Spitzer, W.O. 1994: Beta-agonist use and death from asthma JAMA 271(11): 821-822
Kupryś-Lipińska, I.; Tworek, D.; Vanderbist, F.; Bocheńska-Marciniak, M.łg.; Kuna, P. 2013: Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma Pneumonologia i Alergologia Polska 81(6): 527-536
Bentur, L.; Kerem, E.; Canny, G.; Reisman, J.; Schuh, S.; Stein, R.; Levison, H. 1990: Response of acute asthma to a beta 2 agonist in children less than two years of age Annals of Allergy 65(2): 122-126
Gupta, S.K.; Mitra, K. 1987: Failure of long-acting, recently introduced beta-agonist in asthma Journal of the Indian Medical Association 85(2): 59
Janson, C.; Boman, G.; Boe, J. 1992: Which patients benefit from adding theophylline to beta 2-agonist treatment in severe acute asthma? Annals of Allergy 69(2): 107-110
Solidoro, P.; Donati, G.; Magnoni, M.S. 2003: Fluticasone propionate in the treatment of airway inflammations (asthma and rhinitis) Minerva Pediatrica 55(4): 345-355
Lange, P.; Vestbo, J. 1996: Fluticasone propionate--a new inhalation steroid for the treatment of bronchial asthma Ugeskrift for Laeger 158(4): 439-444
Bianchi, G. 1985: Treatment of asthma syndromes in pediatric patients using a combination of a beta 2-stimulant drug and a histamine antagonist International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 56-58
Anastasatu, C.; Dutu, S.t.; Morgenstern, H. 1983: Possibilities of reducing the doses of beta-adrenergic bronchodilators (Berotec) in combination with an anticholinergic drug (Atrovent) in bronchial asthma Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 32(3): 257-260
Von Berg, A.; Gappa, M.; Steinkamp, G. 2002: Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial European Journal of Medical Research 7(6): 257-264
Purello-D'Ambrosio, F.; Gangemi, S.; Merendino, R.A.; Arena, A.; Guarneri, F.; Ricciardi, L. 1999: Effect of fluticasone propionate on interleukin-12 and interferon-gamma production in patients affected by allergic bronchial asthma Journal of Investigational Allergology and Clinical Immunology 9(4): 262-267
Maneechotesuwan, K.; Assawabhumi, J.; Rattanasaengloet, K.; Suthamsmai, T.; Pipopsuthipaiboon, S.; Udompunturak, S. 2014: Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients Journal of the Medical Association of Thailand 97(Suppl 3): S91-100
Sovijärvi, A.R.A.; Haahtela, T.; Ekroos, H.J.; Lindqvist, A.; Saarinen, A.; Poussa, T.; Laitinen, L.A. 2004: Sustained reduction in bronchial hyperresponsiveness within three days of inhaled fluticasone propionate in mild asthma:time course after onset and cessation of treatment Duodecim; Laaketieteellinen Aikakauskirja 120(13): 1591-1593
Wirtzfeld, A.; Klein, G.; Bibra, H.V.; Sauer, E. 1985: Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity? International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 20-27
Scarpace, P.J.; Abrass, I.B. 1982: Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist Journal of Pharmacology and Experimental Therapeutics 223(2): 327-331
Cohen, M.L.; Ruffolo, R.R.; Wiley, K.S. 1980: Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein Journal of Pharmacology and Experimental Therapeutics 215(2): 325-331